166 related articles for article (PubMed ID: 15124015)
1. Dysbindin-1 and schizophrenia: from genetics to neuropathology.
Owen MJ; Williams NM; O'Donovan MC
J Clin Invest; 2004 May; 113(9):1255-7. PubMed ID: 15124015
[TBL] [Abstract][Full Text] [Related]
2. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.
Talbot K; Eidem WL; Tinsley CL; Benson MA; Thompson EW; Smith RJ; Hahn CG; Siegel SJ; Trojanowski JQ; Gur RE; Blake DJ; Arnold SE
J Clin Invest; 2004 May; 113(9):1353-63. PubMed ID: 15124027
[TBL] [Abstract][Full Text] [Related]
3. Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients.
Fung SJ; Sivagnanasundaram S; Weickert CS
Biol Psychiatry; 2011 Jan; 69(1):71-9. PubMed ID: 21145444
[TBL] [Abstract][Full Text] [Related]
4. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.
Numakawa T; Yagasaki Y; Ishimoto T; Okada T; Suzuki T; Iwata N; Ozaki N; Taguchi T; Tatsumi M; Kamijima K; Straub RE; Weinberger DR; Kunugi H; Hashimoto R
Hum Mol Genet; 2004 Nov; 13(21):2699-708. PubMed ID: 15345706
[TBL] [Abstract][Full Text] [Related]
5. [Advances in the studies of the dysbindin gene in schizophrenia].
Zhao GF; Deng H; Yang YC; Chen Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):175-8. PubMed ID: 19350510
[TBL] [Abstract][Full Text] [Related]
6. The schizophrenia susceptibility gene DTNBP1 modulates AMPAR synaptic transmission and plasticity in the hippocampus of juvenile DBA/2J mice.
Orozco IJ; Koppensteiner P; Ninan I; Arancio O
Mol Cell Neurosci; 2014 Jan; 58():76-84. PubMed ID: 24321452
[TBL] [Abstract][Full Text] [Related]
7. Neuroscience. Vesicular glutamate transporter--shooting blanks.
Schuske K; Jorgensen EM
Science; 2004 Jun; 304(5678):1750-2. PubMed ID: 15205517
[No Abstract] [Full Text] [Related]
8. Schizophrenia susceptibility gene dysbindin regulates glutamatergic and dopaminergic functions via distinctive mechanisms in Drosophila.
Shao L; Shuai Y; Wang J; Feng S; Lu B; Li Z; Zhao Y; Wang L; Zhong Y
Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18831-6. PubMed ID: 22049342
[TBL] [Abstract][Full Text] [Related]
9. Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.
Jentsch JD; Trantham-Davidson H; Jairl C; Tinsley M; Cannon TD; Lavin A
Neuropsychopharmacology; 2009 Nov; 34(12):2601-8. PubMed ID: 19641486
[TBL] [Abstract][Full Text] [Related]
10. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin.
Talbot K; Cho DS; Ong WY; Benson MA; Han LY; Kazi HA; Kamins J; Hahn CG; Blake DJ; Arnold SE
Hum Mol Genet; 2006 Oct; 15(20):3041-54. PubMed ID: 16980328
[TBL] [Abstract][Full Text] [Related]
11. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.
Weickert CS; Rothmond DA; Hyde TM; Kleinman JE; Straub RE
Schizophr Res; 2008 Jan; 98(1-3):105-10. PubMed ID: 17961984
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic vesicular glutamate transporter 2-immunoreactive input to septohippocampal parvalbumin-containing neurons: novel glutamatergic local circuit cells.
Hajszan T; Alreja M; Leranth C
Hippocampus; 2004; 14(4):499-509. PubMed ID: 15224985
[TBL] [Abstract][Full Text] [Related]
13. Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia.
Smith RE; Haroutunian V; Davis KL; Meador-Woodruff JH
Neuroreport; 2001 Sep; 12(13):2885-7. PubMed ID: 11588596
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.
Larimore J; Zlatic SA; Gokhale A; Tornieri K; Singleton KS; Mullin AP; Tang J; Talbot K; Faundez V
J Biol Chem; 2014 May; 289(20):14291-300. PubMed ID: 24713699
[TBL] [Abstract][Full Text] [Related]
15. Nucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expression.
Fei E; Ma X; Zhu C; Xue T; Yan J; Xu Y; Zhou J; Wang G
J Biol Chem; 2010 Dec; 285(49):38630-40. PubMed ID: 20921223
[TBL] [Abstract][Full Text] [Related]
16. Dysbindin and Schizophrenia: it's dopamine and glutamate all over again.
Papaleo F; Weinberger DR
Biol Psychiatry; 2011 Jan; 69(1):2-4. PubMed ID: 21145442
[No Abstract] [Full Text] [Related]
17. Cellular localization of three vesicular glutamate transporter mRNAs and proteins in rat spinal cord and dorsal root ganglia.
Oliveira AL; Hydling F; Olsson E; Shi T; Edwards RH; Fujiyama F; Kaneko T; Hökfelt T; Cullheim S; Meister B
Synapse; 2003 Nov; 50(2):117-29. PubMed ID: 12923814
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.
Eastwood SL; Harrison PJ
Schizophr Res; 2005 Mar; 73(2-3):159-72. PubMed ID: 15653259
[TBL] [Abstract][Full Text] [Related]
19. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
[TBL] [Abstract][Full Text] [Related]
20. The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the Synapse.
Gokhale A; Hartwig C; Freeman AH; Das R; Zlatic SA; Vistein R; Burch A; Carrot G; Lewis AF; Nelms S; Dickman DK; Puthenveedu MA; Cox DN; Faundez V
J Neurosci; 2016 Dec; 36(49):12393-12411. PubMed ID: 27927957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
